Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Killing the golden goose of US drug innovation (Part I): Follow the money
Americas
In the first of a two-part series, Mercedes Meyer of Banner Witcoff and Brandon Phemester of Novavax explore how legislative, judicial, and executive policies have dramatically altered the risks for drug innovation.   10 September 2025
Buchalter brings in new partner to head up medtech
Careers
The firm’s medtech practice will be led by a partner with experience in digital health, medical devices, and emerging technologies, with particular expertise in advising startups.   10 September 2025
Trump’s march-in rights threat: Why pharma is rethinking collaborations
Americas
Federal oversight, funding cuts, and patent uncertainties are forcing universities, startups, and pharma companies to reassess partnership models, finds Marisa Woutersen.   9 September 2025
Careers
Wales’ first MP of ethnic minority background brings tech knowledge and expertise to the IP office, which is carrying out two pivotal consultations.   9 September 2025
Careers
The US firm has ramped up its business growth strategy with the new hires, who will represent different IP practice and industry areas.   8 September 2025
Careers
Appointment is the third ex-PTAB staffer to join, strengthens the firm’s position as a “PTAB powerhouse”.   8 September 2025
Americas
The UK pharma giant has opened a new front in its global litigation strategy involving Moderna, Pfizer, and BioNTech.   5 September 2025
Americas
The Finnish wearable tech brand is fighting hard to fend off younger rivals, with the battleground getting bloody. Sarah Speight reports.   5 September 2025
Europe
The company’s EPO victory over a rare disease biomarker patent highlights how precise claims and attention to objections can make or break biotech cases, reports Marisa Woutersen.   4 September 2025
Americas
The deal brings to a close a clash over DNA sequencing technology for cancer detection, with both sides agreeing to dismiss their claims.   4 September 2025